Back
Theriva Biologics Stock Price Chart

The key to a $1.3T opportunity
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
35
TOVX
Theriva Biologics
Last Price:
$1.34
Seasonality Move:
-12.09%
7 Day Trial
ALL ACCESS PASS
$
7

Top investors are buying this "unlisted" stock
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TOVX is experiencing buying pressure, which is a positive indicator for future bullish movement.
Theriva Biologics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.24 | Buy |
20-day SMA: | 1.19 | Buy |
50-day SMA: | 1.32 | Buy |
200-day SMA: | 2.54 | Sell |
8-day EMA: | 1.28 | Buy |
20-day EMA: | 1.23 | Buy |
50-day EMA: | 1.29 | Buy |
200-day EMA: | 3.16 | Sell |
Theriva Biologics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.01 | Buy |
Relative Strength Index (14 RSI): | 57.25 | Buy |
Chaikin Money Flow: | 11339 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.09 - 1.29) | Buy |
Bollinger Bands (100): | (1.17 - 1.53) | Buy |
Theriva Biologics Technical Analysis
Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 14 | Apr 15 | Apr 16 | Apr 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Theriva Biologics Stock
Is Theriva Biologics Stock a Buy?
-
Theriva Biologics share price is 1.36 while TOVX 8-day simple moving average is 1.24, which is a Buy signal.
-
The stock price of TOVX is 1.36 while Theriva Biologics 20-day SMA is 1.19, which makes it a Buy.
-
Theriva Biologics 50-day simple moving average is 1.32 while TOVX share price is 1.36, making it a Buy technically.
-
TOVX stock price is 1.36 and Theriva Biologics 200-day simple moving average is 2.54, creating a Sell signal.
TOVX Technical Analysis vs Fundamental Analysis
Sell
35
Theriva Biologics (TOVX)
is a Sell
Is Theriva Biologics a Buy or a Sell?
-
Theriva Biologics stock is rated a SellThe current Theriva Biologics [TOVX] share price is $1.36. The Score for TOVX is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
Theriva Biologics Stock Info
Market Cap:
3.8M
Price in USD:
1.36
Share Volume:
12.4K
Theriva Biologics 52-Week Range
52-Week High:
12.28
52-Week Low:
0.96
Sell
35
Theriva Biologics (TOVX)
is a Sell
Theriva Biologics Share Price Forecast
-
What is the Theriva Biologics stock price today?The Theriva Biologics stock price is 1.36 USD today.
-
Will TOVX stock go up or go down?Theriva Biologics> share price is forecast to RISE/FALL based on technical indicators
-
Is Theriva Biologics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Theriva Biologics is overvalued.
Is Theriva Biologics Stock a Buy?
-
Theriva Biologics share price is 1.36 while TOVX 8-day exponential moving average is 1.28, which is a Buy signal.
-
The stock price of TOVX is 1.36 while Theriva Biologics 20-day EMA is 1.23, which makes it a Buy.
-
Theriva Biologics 50-day exponential moving average is 1.29 while TOVX share price is 1.36, making it a Buy technically.
-
TOVX stock price is 1.36 and Theriva Biologics 200-day simple moving average is 3.16, creating a Sell signal.
Fundamental Analysis of Theriva Biologics
Is Theriva Biologics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $22.60 per share, and a decrease next year of $0.00 per share.
Technical Analysis of Theriva Biologics
Should I short Theriva Biologics stock?
-
TOVX Moving Average Covergence Divergence (MACD) indicator is 0.01, suggesting Theriva Biologics is a Buy
-
Theriva Biologics Relative Strength Index (RSI) is 57.25, which suggest Theriva Biologics is overbought
-
The Bollinger Bands (25) for Theriva Biologics is (1.09 - 1.29), which suggest Theriva Biologics is a Buy
-
The Bollinger Bands (100) for Theriva Biologics is (1.17 - 1.53), which suggest Theriva Biologics is a Buy
* Theriva Biologics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.